Clinical Trial: A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07489599) titled 'A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease' on March 18.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of QLH2405 injection in healthy participants and participants with mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild Alzheimer's disease.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease(AD) Mild Cognitive Impairment (MCI)

Intervention: DRUG: QLH2405

QLH2405 will be administere...